pharma · Atopic Dermatitis · Alopecia Areata
Forteo
Forteo is a pharma organization headquartered in Las Vegas, USA. Primary therapeutic focus areas include Atopic Dermatitis, Alopecia Areata, Celiac Disease, Vitiligo, Osteoarthritis, Knee. NovaPharmaNews links 5 clinical
Las Vegas, USA HQ
20 Employees
PMDA registrant Type
Company details
- Status
- Public
- HQ
- Las Vegas, USA
- Employees
- 20
- Programs
- 5
- Drugs
- 0
- Patents
- 3
FB-401
Phase 2 · mab · Atopic Dermatitis
FB-401 for Atopic Dermatitis is a Phase 2 program (mab) at Forteo with 2 ClinicalTrials.gov record(s).
Internal code FB401-02
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Forteo
- Phase
- Phase 2
- Modality
- mab
- Indication
- Atopic Dermatitis
- Status
- terminated
- Trials
- 2